Your Mounjaro price guide · October 2026
Which Weight Loss Medication Suits You With Diabetes? UK (October 2026)
There is no single best weight loss diabetes medication: the right choice depends on your diabetes type, your other medicines and your prescriber's assessment. Mounjaro (tirzepatide) is licensed in the UK for weight management in adults and for type 2 diabetes, and it activates two gut-hormone receptors rather than one. Semaglutide-based medicines are the main alternatives. Any change should be agreed with your diabetes team. Information current as of October 2026.
One pen. Four weekly doses.
New customers£40 off your first order with code FIRST40. Standard price £169.99.

From your first consultation to ongoing care.
- GPhC-registered UK pharmacy
- Prescriber assessment
- Temperature-controlled delivery
- Advice from our pharmacy team
Compare UK Mounjaro Prices
Prices checked 11 October 2026
| Provider | 2.5mg | 5mg | 7.5mg | 10mg | 12.5mg | 15mg | Notes |
|---|---|---|---|---|---|---|---|
| £129.99First orderReorders £144.99 | £178.99First orderReorders £193.99 | £239.99First orderReorders £254.99 | £250.99First orderReorders £265.99 | £279.99First orderReorders £294.99 | £289.99First orderReorders £304.99 | Consultation and next-day tracked delivery included | |
| Boots Online Doctor | £179.00 | £199.00 | £259.00 | £299.00 | £319.00 | £339.00 | Free click & collect; cold-chain home delivery chargeable |
| Asda Online Doctor | £148.97 | £188.97 | £248.97 | £278.97 | £287.47 | £298.97 | Refrigerated delivery from £4.50; free click & collect |
| MedExpress | £179.99 | £189.99 | £249.99 | £279.99 | £299.99 | £309.99 | Delivery £2.90 to £3.95; new-customer discount at checkout |
| Simple Online Pharmacy | £169.00 | £199.99 | £259.99 | £279.99 | £299.99 | £319.99 | Delivery £4.99 per order |
| Oxford Online Pharmacy | £143.96 | £188.96 | £248.96 | £278.96 | £288.96 | £309.95 | Free consultation; cold delivery £5.49 |
| Chemist4U | £148.00 | £188.00 | £248.00 | £278.00 | £288.00 | £298.00 | Consultation included; free temperature-controlled delivery |
| Chemist Click | £163.99 | £173.99 | £232.99 | £259.99 | £279.99 | £299.49 | Cold-chain delivery charged; £20 off with code |
| Click Pharmacy | £169.99 | £189.99 | £239.99 | £269.99 | £289.99 | £299.99 | Free assessment; delivery £3.50 to £7.95 |
| Medino | £147.99 | £169.99 | £249.99 | £269.99 | £299.99 | £319.99 | Consultation and delivery included |
Prices collected weekly from each provider's published price list.
A quick overview
What to know
before you start.
-
Mounjaro is licensed in the UK for weight management and for type 2 diabetes, so it sits in both conversations.
-
Tirzepatide activates two gut-hormone receptors; semaglutide medicines such as Wegovy and Ozempic act on a single one.
-
Insulin and sulfonylurea doses may need reducing when you start, to avoid low blood sugar.
-
Tell your usual diabetes team about any change so your care stays joined up.
-
Private treatment is reviewed by a GPhC-registered prescriber; NHS access is being phased in over several years.
In this guide
01 · The short answer
Which diabetes medication is best for weight loss?
The right medicine for you is the one that is licensed for your situation, that suits your other treatments and that you can stay on. Mounjaro is licensed for weight management in adults and for type 2 diabetes. The licence is only the starting point, though. A prescriber also looks at your blood sugar, your kidney and digestive health, your current tablets or insulin and your goals.
Mounjaro is the brand name for tirzepatide, a once-weekly injectable prescription medicine made by Eli Lilly.1 Its mechanism is what sets it apart from semaglutide medicines such as Wegovy and Ozempic. Tirzepatide activates two natural gut-hormone receptors at once, GIP and GLP-1, and this dual action is what distinguishes Mounjaro from single-action GLP-1 medicines such as semaglutide (Wegovy/Ozempic).1 That is a difference in how the medicines work. It is not a promise about how any one person will respond, and individual results vary.
02 · Your next step
The two decisions most readers face
The first decision is whether you should be on a weight-focused medicine at all, or whether your diabetes treatment should simply be reviewed. If your diabetes is already managed by your GP or diabetes nurse, the simplest first step is to ask them whether a medicine that supports weight loss could replace or sit alongside your current plan. They hold your blood results and your full history, so they are best placed to advise.
The second decision is how to access treatment. NHS access is being phased in over several years, and some people choose regulated private treatment instead. If you go that route, the key safeguard is full honesty about your diabetes and every medicine you take. Mounjaro is a prescription-only medicine, supplied only after an online consultation reviewed by a GPhC-registered prescriber. It is used alongside a reduced-calorie diet and increased physical activity.1
| Question to ask | Why it matters |
|---|---|
| Is the medicine licensed for my situation? | Mounjaro is licensed for weight management in adults and for type 2 diabetes; other products have different licences. |
| Do I take insulin or a sulfonylurea? | Doses may need reducing to avoid low blood sugar. |
| Do I take warfarin or other narrow-margin medicines? | Slower stomach emptying can change how quickly some oral medicines are absorbed. |
| Does my diabetes team know? | Joined-up care means monitoring is coordinated. |
| Can I keep it up long term? | Cost, side effects and routine all affect whether treatment lasts. |
03 · Where to go next
A soft pathway if you are ready
If you have talked it through with your diabetes team and want to look at private treatment, you can see the Mounjaro pen, prices and consultation. Your first 2.5mg pen costs £129.99 with code FIRST40 (standard price £169.99). The free consultation is reviewed by a GPhC-registered prescriber, who decides whether treatment is suitable. Unsuitable orders are refunded automatically. You can also browse our weight loss clinic for wider guidance.
If you are still comparing, our guide to the best diabetes drug for weight loss goes deeper on individual options.
04 · How these medicines work
Why diabetes medicines can cause weight loss
Some diabetes medicines cause weight loss because they act on the gut hormones that control appetite and digestion. Not every diabetes medicine does this. Some older treatments are neutral for weight, and some can contribute to weight gain, which is why this question matters so much to people living with diabetes. The medicines that help with weight are the ones that mimic or enhance natural hormones released after eating.
Tirzepatide is the first treatment of its kind to activate two natural gut-hormone receptors at once: GIP and GLP-1. Together these help regulate appetite, slow how quickly the stomach empties, and improve the way the body responds to insulin.1 In practice, most people feel fuller sooner and less hungry between meals, which supports a reduced-calorie diet.1
For someone with diabetes, that combination is relevant for two reasons. Better response to insulin supports blood sugar control, and reduced appetite supports weight management. The two effects are linked, because weight and blood sugar influence each other. That is why a medicine licensed for both can be attractive.
It is worth being honest about what a mechanism does not tell you. Knowing that a medicine acts on two receptors does not tell you how much weight you will lose, how your blood sugar will change or how well you will tolerate it. Those depend on your body, your starting point, your diet and activity, and your dose. Trial averages do not predict your own result, and anyone who promises a specific outcome is not being straight with you.
Our explainer on why diabetes medication causes weight loss walks through the same ideas in more depth, including why some medicines affect weight differently from others.
Tirzepatide has a half-life of about five days, so after a final dose it takes roughly four to five weeks to clear the system. There is no way to speed this up, and nothing needs doing while it clears.1 This is useful to know if you ever need to stop, for example before planning other treatment, because the effects fade gradually rather than overnight. Always discuss stopping with your prescriber first, particularly if you also take other diabetes medicines whose doses may then need to change.
In short, the mechanism explains why this class of medicine is so widely discussed for weight and diabetes together, but the decision still rests on a clinical assessment of you as an individual.
05 · Mounjaro and Ozempic
Which is better, Ozempic or Mounjaro?
Neither is better for everyone, and an honest answer starts with what each medicine is. Mounjaro is tirzepatide. Ozempic is semaglutide. Both are once-weekly injections that act on gut-hormone pathways. The main structural difference is that tirzepatide activates two receptors while semaglutide activates one.1
Numbers from separate trials, run in different populations with different designs, are not a fair comparison, and readers regularly draw wrong conclusions from them. What matters more in practice is a set of personal questions your prescriber can help with.
First, what is the medicine licensed for? Mounjaro is licensed in the UK for weight management in adults and for type 2 diabetes.1 Ozempic is semaglutide licensed for type 2 diabetes only; it is not a UK weight-loss medicine, and prescribing it for weight loss is off-label. Wegovy is the semaglutide product licensed for weight management. If your main goal is weight, the product with a weight-management licence is the natural starting point. If your main goal is blood sugar, your diabetes team will usually lead.
Second, how will you tolerate it? Side effects are mostly digestive and tend to be most noticeable when you start or increase the dose. A slow step-up helps, which is why Mounjaro begins at the lowest strength and increases in stages. Your prescriber guides this and reviews how you are getting on.
Third, what is available and affordable to you? NHS pathways, private prices and your personal circumstances all shape the realistic choice. A medicine you can stay on consistently matters more than one you cannot sustain.
Fourth, what else do you take? Insulin, sulfonylureas and narrow-margin medicines such as warfarin all need attention, whichever product you choose.
If you want a broader look at the semaglutide-versus-tirzepatide question, see what is the best GLP-1 medication for weight loss. For the diabetes-specific angle, our page on best diabetes drugs for weight loss in the UK is a useful companion.
The takeaway is simple. Treat any claim that one brand is universally better with caution. The right option is the licensed one that fits your health, your other medicines and your life, chosen with a clinician who has seen your records.
06 · Mounjaro with diabetes
Using Mounjaro if you have diabetes
If you have diabetes, Mounjaro needs extra coordination because it can change how your other treatments behave. Mounjaro is also licensed for type 2 diabetes, where it improves blood sugar control (HbA1c) and supports weight loss.1 If you have type 2 diabetes, treatment and monitoring are coordinated differently — tell your prescriber and your usual diabetes team so care stays joined up.1
In practice, that means being open at the consultation about your diagnosis, how long you have had it, and every tablet or injection you take. The prescriber needs the whole picture to judge suitability and to tell you what to watch for. It also means keeping your GP surgery or diabetes clinic in the loop so that blood tests and reviews continue as normal.
The most important safety point is low blood sugar. Because Mounjaro slows stomach emptying, it can affect how quickly some oral medicines are absorbed, particularly when you start treatment or increase the dose.1 Tell your prescriber about everything you take, especially warfarin or other narrow-margin medicines, insulin, or sulfonylureas, where doses may need reducing to avoid low blood sugar.1 No adjustment is needed for paracetamol.1
Doses may need adjusting, but that adjustment is a clinical decision made with you, not something to attempt on your own by skipping or changing a dose without advice.
Monitoring matters too. If you check your own blood sugar, keep doing so as your prescriber and diabetes team advise, and tell them about any symptoms that worry you. New or unusual symptoms should be discussed with your prescriber, and you can report suspected side effects through the Yellow Card scheme.7
Our guide to weight loss injection medication for diabetes looks at the injectable options.
Finally, remember that a weight-loss medicine is a tool, not a replacement for the basics. It is used alongside a reduced-calorie diet and increased physical activity, and your diabetes team can help you tailor both safely.
07 · NHS or private
NHS access versus private treatment
Mounjaro is available on the NHS, but access is being phased in over several years. NICE recommends it for adults with a BMI of at least 35 plus at least one weight-related condition, and the NHS primary-care rollout began in June 2025 with the highest-need groups first (initially BMI 40+ with four or more qualifying conditions).4 Full rollout is expected to take years, which is why many people who meet the licensed criteria choose regulated private treatment rather than waiting.6
Eligibility for Mounjaro on the NHS follows NICE guidance and local rollout, and your GP or local service can tell you where you stand.
If you want to ask your GP, a few practical steps help. Book a routine appointment and say clearly that you want to discuss medicines for weight management alongside your diabetes. Bring your recent weight, your blood results if you have them, and a list of what you take. Ask whether you meet the current criteria locally and, if not, when you might. Ask also whether any of your existing diabetes medicines could be changed to ones that are kinder to your weight.
Why might a doctor not prescribe it? Usually because you do not yet meet the criteria being applied locally, because another treatment suits your diabetes better, or because there are safety considerations in your history. None of those reasons is a judgement on you. Ask what would change the answer and whether a referral to a specialist weight-management service is possible.
Private treatment is the alternative route. A private prescriber still has to assess suitability, and the same safety issues apply, including those around insulin and sulfonylureas. Payment is taken when you place the order; if the prescriber decides the treatment is not suitable, the order is refunded automatically in full. Ongoing monthly reviews, dose-titration and follow-up assessments are carried out by the prescribing team.
You can read more about the private route in our guide to weight loss medication prescriptions with diabetes. Whichever route you choose, tell your usual diabetes team so everyone is working from the same information.
Wegovy access also runs through specialist weight-management services on the NHS, so ask your GP about it.
08 · Who it may suit
Who Mounjaro may suit, and who needs extra care
Mounjaro may suit adults with diabetes who also need to manage weight, provided a prescriber judges it safe and appropriate. The licence matters here. Mounjaro is licensed in the UK for weight management in adults and for type 2 diabetes.1 For private weight-management treatment, prescribers commonly look at your body mass index, with thresholds such as 27, 30, 35 and 40 kg/m² used in different contexts, alongside weight-related conditions. Your prescriber explains which applies to you.
The NHS guidance is more specific. NICE recommends it for adults with a BMI of at least 35 plus at least one weight-related condition, and the rollout began with the highest-need groups first.4 Private prescribing follows the licence and the prescriber's clinical judgement, which is different from NHS commissioning rules, so meeting one set of criteria does not automatically mean meeting the other.
Who needs extra care? Anyone taking insulin or a sulfonylurea, because doses may need reducing to avoid low blood sugar. Anyone on warfarin or other narrow-margin medicines, because slower stomach emptying can change absorption. Anyone who has had significant digestive problems, kidney concerns or pancreatitis in the past should raise it, because the prescriber must weigh these. Always share your full medical history and medicine list during consultation.
Pregnancy and contraception also need attention. The medicine can reduce absorption of oral contraceptives because stomach emptying slows, so ask your prescriber about your options before starting.7 The SmPC advises switching to a non-oral method, or adding a barrier method (such as condoms), for 4 weeks after starting Mounjaro and for 4 weeks after each dose increase.1 Mounjaro must not be used during pregnancy, and it should be stopped at least one month before trying to conceive. If you become pregnant during treatment, stop the medicine and tell your prescriber promptly.
Who is probably better served elsewhere? Someone whose diabetes is poorly controlled and unstable may need their diabetes team to stabilise treatment first. Someone whose main need is blood sugar rather than weight may be best served by whatever their clinic recommends. And someone who does not want an injection may prefer to discuss other options with their prescriber.
Be wary of anyone offering to supply without a consultation or prescription. Genuine prescription medicines are supplied only after a clinical review. Our supply is official LillyDirect supply: Mounjaro direct from Eli Lilly's UK distribution, genuine KwikPens, with all six strengths stocked.
If you are unsure whether you fit, the free consultation is no obligation. The prescriber can decline an order, in which case it is refunded automatically in full.
09 · Pills and alternatives
What about weight loss pills and other alternatives?
Which weight loss pill suits someone with diabetes depends on licence and prescriber judgement rather than a single winner. Tablet options exist, including Wegovy tablets and Foundayo, and each has its own product information. Ask your prescriber which tablet, if any, is suitable alongside your diabetes treatment.
Injectable alternatives are better documented. Wegovy is semaglutide, with a dose ladder of 0.25mg, 0.5mg, 1mg, 1.7mg and 2.4mg once weekly. The 2.4mg dose is the licensed maintenance dose for weight management.18 Mounjaro, by comparison, comes in six strengths from 2.5mg to 15mg and is also once weekly.
Liraglutide, sold as Saxenda and in products such as Erly, is different in an important practical way. It is supplied at a concentration of 6mg per millilitre and is a daily injection, unlike once-weekly Mounjaro and Wegovy. Some people prefer the weekly routine; others are happy with a daily one.
Then there are the non-prescription products. Low-cost supplements promoted as natural alternatives, sometimes with nicknames borrowed from prescription medicines, are available cheaply without assessment and without clinical oversight. Dosing is not standardised, and dramatic weight-loss claims attached to them should be treated with scepticism. They are not an established substitute for licensed medicines, and anyone with diabetes should speak to their team before taking anything that might affect blood sugar.
Do not forget that the lifestyle foundation applies to every option. All of these medicines are used alongside a reduced-calorie diet and increased physical activity. Medication works with those habits, not instead of them.
If you start a new medicine and notice a symptom you did not expect, tell your prescriber and report it via the Yellow Card scheme.19
10 · Serious side effects
Serious side effects: when to get help straight away
Serious side effects are uncommon but need urgent attention. Seek immediate medical help for: severe, persistent stomach pain that may spread to your back, with or without vomiting (possible pancreatitis); pain in the upper right abdomen, fever or yellowing of skin/eyes (possible gallbladder problems); or signs of a severe allergic reaction such as swelling of the face or throat and difficulty breathing. If you take insulin or a sulfonylurea alongside Mounjaro, watch for low blood sugar (shakiness, sweating, confusion) — your prescriber may need to adjust those medicines.1
11 · Ordering and aftercare
How private ordering and aftercare work
Private ordering at EverydayMeds follows four plain steps. First, you complete a free online consultation, a short health questionnaire with no charge and no obligation. Second, your consultation is reviewed by a GPhC-registered prescriber; payment is taken when you place the order, and if the prescriber decides the treatment is not suitable, the order is refunded automatically in full. Third, our registered pharmacy dispenses the order, with same-day dispatch when you order by 3pm. Fourth, delivery is free, next-day and tracked, using temperature-controlled, discreet packaging. Saturday delivery is £14.99.
Cost is worth planning for. Each standard monthly pen price depends on dose: the 2.5mg pen is £169.99, the 5mg pen £218.99, and higher strengths follow. If you step up after 4 weeks on each dose, your first four pens (2.5mg to 10mg) cost £959.96 at standard prices. A first year costs £2,711.88 if you stay on 5mg after your 2.5mg starting pen, up to £3,599.88 if you step up through every dose to 15mg. Those totals are before discounts: a new customer's first order is £40 less with code FIRST40, and an automatic £25 reorder discount applies to every future order (code DOSE25). The price shown is the price paid, and the consultation itself is free. You can pay by card, Klarna or pay-monthly options, with no subscription lock-in. Prices were checked 11 October 2026.
Supply matters for safety. Our Mounjaro is sourced directly from Eli Lilly's UK distribution, and our pharmacy is registered with the GPhC (9012878). Counterfeit pens are a real risk when buying from unregulated sellers, so check any pharmacy's registration on the public register and report concerns through the MHRA channels.7
Aftercare includes ongoing monthly reviews, dose-titration and follow-up assessments by the prescribing team, plus side-effect support. Repeat orders re-check suitability, and nothing ships automatically. For anyone with diabetes, these reviews are a chance to flag blood sugar changes or adjustments your diabetes team has made. Needles, a sharps bin and injection guidance come with every order, and our free GLPTrackr app helps you log your journey.
Storage is straightforward. Keep pens in the fridge at 2–8°C until first use, and they keep until the printed expiry date. Once in use, a KwikPen can be kept out of the fridge at a temperature not above 30°C for up to 30 days after first use, and must then be thrown away. Do not use a pen that has been above 30°C or has been frozen. Follow the pen's instructions and the patient information leaflet for the injection itself.13
Support is available on weekdays by email at support@everydaymeds.co.uk, through the account portal chat or by phone. Dispensed prescription medicines cannot be returned except where faulty, damaged or the wrong item.
How ordering works
How ordering works at EverydayMeds
Three steps, with our pharmacy team alongside you.
Step 1: Online consultation — 5–10 minutes
Complete a confidential health questionnaire covering BMI, medical history and current medication. No payment is taken until you're approved.
Step 2: Prescriber review — usually same day
A UK registered prescriber checks your suitability against the licensed criteria (BMI ≥30, or ≥27 with a weight-related condition) and contraindications, and confirms your starting dose.
Step 3: Next-day tracked delivery
Dispensed by our GPhC-registered pharmacy in temperature-controlled packaging with needles and a sharps bin included. Orders approved by 3pm for next-day tracked delivery.
Prescription and dispatch follow clinical approval. Confirm current delivery options when ordering.
Afterwards you're not on your own: dose-change reviews are built in before each step up, our pharmacist team is available for side-effect questions, and repeat orders re-check suitability rather than auto-shipping.
Your questions, answered
Mounjaro price UK — frequently asked questions
Answers to common questions about Mounjaro prices, NHS access and ongoing treatment.
Ask our pharmacy teamWhat is the best weight loss diabetes medication?
Which diabetes medication suits weight loss best for me?
Which is better, Ozempic or Mounjaro?
Which weight loss pill suits people with diabetes?
Who qualifies for Mounjaro on the NHS?
How to ask GP for Mounjaro?
Why won't my doctor prescribe me Mounjaro?
Can I take Mounjaro with insulin or other diabetes tablets?
How much weight can you lose on Mounjaro in three months?

Clinically reviewed by
Mahommed Zunaid Ayub Patel
Superintendent Pharmacist
Accountable for the safe running of our registered pharmacy — from dispensing checks to delivery.
GPhC registration no. 2217101 · check the GPhC register
- Reviewed
- Last updated
- Next review
How we source our information
How we source our information: every clinical statement on this page is drawn from the sources below. Our prices are shown live from our pharmacy's product listings, and competitor prices show the date they were collected.
Sources — 10 references
- Mounjaro KwikPen — Summary of Product Characteristics (SmPC), electronic medicines compendium (EMC), 2026
- NICE TA1026 — Tirzepatide for managing overweight and obesity, including the practical prescribing guide
- NHS — Tirzepatide: medicine to manage type 2 diabetes and treat obesity
- NHS England — Weight management injections: rollout guidance
- MHRA — guidance on contraception with GLP-1/GIP medicines; counterfeit medicine alerts and Yellow Card scheme
- Mounjaro KwikPen — Patient Information Leaflet (emc)
- Wegovy — Summary of Product Characteristics (SmPC), electronic medicines compendium (EMC)
- MHRA Yellow Card scheme — report a side effect
- Wegovy tablets (oral semaglutide) — Summary of Product Characteristics (SmPC), electronic medicines compendium (EMC), 2026
- Foundayo (orforglipron) film-coated tablets — Summary of Product Characteristics (SmPC), electronic medicines compendium (EMC), 2026
EverydayMeds is operated by OVIO Ltd · GPhC-registered pharmacy 9012878 · Registered premises, Leicester · Superintendent Pharmacist: Mahommed Zunaid Ayub Patel


